Journal of Experimental Pathology

Rameen Shakur

Precision and Regenerative Medicine

Massachusetts Institute of Technology

USA

Academic Editor

Biography

Dr Rameen Shakur MD PhD (Cantab) is an academic clinician and biologist in molecular mechanisms of regeneration and applications of precision medicine at the Massachusetts Institute of Technology , Boston USA . Dr Shakur undertook his undergraduate studies at the University of Cambridge, UK where he completed his MPhil in Immunology and completed his medical studies at the University of Edinburgh. He completed his clinical training at the John Radcliffe Hospital, University of Oxford, UK. He undertook cardiology training in imaging at the Royal Brompton hospital, London. He was awarded the Winston Churchill fellowship at Harvard medical school where he undertook work in Prof Peter Libby's lab and also at the Mayo Clinic, Rochester at Prof Mike Ackerman's lab . He completed his PhD at the University of Cambridge at the Wellcome trust Sanger centre and the laboratory of regenerative medicine. During his PhD he was awarded the Isabelle Buohon award to undertake work on genome editing in human IPS cells at Prof George Church's lab at Harvard. He undertook his post doctoral work at Prof Bob Langer's lab as the inaugural Janson fellow at the Koch institute for integrative cancer research at MIT.

His work centres upon delineation of the mechanism of action of inhertied cardiac diseases and novel drug development for precision cardiology utilising a systems biology perspective, inflammation and modulation of connexins and therapies for drug discovery in cardiovascular disease. He is also been instrumental for a number of the important papers on novel models for the phenotype genotype disparities in the inherited cardiomyopathies.

Research Interest

Dr Rameen Shakur has an unique research portfolio given his background as a clinician scientist in cardiovascular disease. He is interested in enhancing the understanding of mechanism of action for hypoxia induced inflammation and initiators for hypertophic process in inherited cardiomyopathies. He has been the recipient of a number of awards and was given awards for the application for novel technologies and mechanistic understandings at the international Nanomedicine conference and at the World synthetic biology conference. He was also the recipient of the World changing ideas 2019 by Fast company for his application of translational development of novel applications for artificial intelligence in healthcare.